Status
Terminated
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Status
Terminated
Classification
Class II
Report Date
February 12, 2025
Termination Date
July 17, 2025